Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Deficiency of the alkaline ceramidase ACER3 manifests in early childhood by progressive leukodystrophy.
BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in Multiple Sclerosis patients.
The RESTORE trial: What did we learn about multiple sclerosis?
Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration.
The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.
Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge.
Immune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk Factors.
Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury.
[Vitamin D in Multiple Sclerosis].
Diffusion-weighted imaging and demyelinating diseases: new aspects of an old advanced sequence.
If I had clinically isolated syndrome with magnetic resonance imaging diagnostic of multiple sclerosis, I would take vitamin D 10,000 IU daily: Yes.
Interferon beta-associated recurrence of painful trigeminal neuropathy attributed to a multiple sclerosis plaque.
Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β
Aging-associated changes in motor axon voltage-gated Na(+) channel function in mice.
Dynamic Assessment of Social Cognition in Individuals with Multiple Sclerosis: A Pilot Study.
Living with the unexplained: Coping, distress, and depression among women with chronic fatigue syndrome (CFS) and/or fibromyalgia comparedto an autoimmune disorder.
Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.
Selective dorsal rhizotomy for spasticity not associated with cerebral palsy: reconsideration of surgical inclusion criteria.
Open Ring Sign Diagnostic of Multiple Sclerosis in the Emergency Department.
Extensive cerebral white matter involvement in a patient with NMO spectrum disorder.
Aquaporin-4 autoimmunity.
Improving communication with multiple sclerosis patients.
IL-27-induced modulation of autoimmunity and its therapeutic potential.

Pages